Genetic S.p.A Polfarmex S.A.
PolandAll drugs from this manufacturer
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing.
Dosage form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 50 mcg salmeterol xinafoate 36.32 mcg ATC: R03AK06
-
The medicine is used for the treatment of bronchial asthma (in individuals requiring long-term anti-inflammatory treatment), croup syndrome (acute inflammation of the larynx, trachea, and bronchi characterized, among other things, by a barking cough), and exacerbations of chronic obstructive pulmonary disease (COPD).
Dosage form: suspension for nebulization
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
-
The medicine is used in the treatment of bronchial asthma (in individuals requiring long-term use of glucocorticosteroids), in cases of croup syndrome (acute inflammation of the larynx, trachea, and bronchi manifesting as shortness of breath or a barking cough), and in exacerbations of chronic obstructive pulmonary disease (COPD).
Dosage form: suspension for nebulization
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02